Dr. Terlinsky Attends the Precision Medicine Workshops Recently
Reproduced with permission from Jeanette McCarthy Ph.D of Precision Medicine Advisers
The Precision Medicine Initiative was begun formally in 2009 and it involves using a person’s genetic information (genomics) to customize a health plan over the course of that person’s lifetime to optimize health and avoid chronic disease.
Reproduced with permission from Jeanette McCarthy Ph.D of Precision Medicine Advisers
Specifically, Precision Medicine, through genomics seeks early detection of various cancers, cardiovascular disease and degenerative neurological diseases including parkinsonism and Alzheimer’s. Moreover, matching a patient with specific medications for conditions based on genomic information may lead to better control of neuropsychiatric conditions, epilepsy, hypertension, cardiovascular disease and many other medical conditions. This is known as pharmacogenomics.
The key to Precision Medicine is a person’s individual variability in their genes and how epigenetic factors such as environment and lifestyle interact to influence the expression of their genes.
This approach will allow physicians to predict the best treatments and prevention strategies for individuals based on their genes. The “ one size fits all “ approach will no longer apply.
The entirety of a person’s genetic material is referred to as their genome. When the human genome was completely decoded around the year 2000, one could have their genetic code deciphered but it was very expensive approaching $30,000. Over the ensuing years, advances in technology have brought down the cost to the point that for a few hundred dollars a person can have their genetic information including important health information.
I am recommending all my patients to make an appointment with me to discuss genomic testing and the benefits of this testing.
0 Comments